Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer release_rirov7nfh5gphfg2sia2k63uvm

by Jéssica Zani Lacerda, Lívia Carvalho Ferreira, Beatriz Camargo Lopes, Andrés Felipe Aristizábal-Pachón, Marcio Chaim Bajgelman, Thaiz Ferraz Borin, Debora Aparecida Pires de Campos Zuccari

Published in MicroRNA by Bentham Science Publishers Ltd..

2019   Volume 08, Issue 3, p237-247

Abstract

The high mortality rate of breast cancer is related to the occurrence of metastasis, a process that is promoted by tumor angiogenesis. MicroRNAs are small molecules of noncoding mRNA that play a key role in gene regulation and are directly involved in the progression and angiogenesis of various tumor types, including breast cancer. Several miRNAs have been described as promoters or suppressors angiogenesis and may be associated with tumor growth and metastasis. Melatonin is an oncostatic agent with a capacity of modifying the expression of innumerable genes and miRNAs related to cancer.
In text/plain format

Archived Files and Locations

application/pdf   2.1 MB
file_33ze2u6dwja3xaebucgbszqtgy
repositorio.unesp.br (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2019-02-19
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  2211-5366
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 0d5729d9-9291-4eac-bccd-893056d9d335
API URL: JSON